GRAIL logo
GRAIL
GRAL | NASDAQ
Chart Builder DCF Calculator
$105.60
-$10.29 (-8.88%)
At close: Nov 16, 2026, 4:00 PM ET
$106.90
+$1.30 (+1.23%)
After-hours: Nov 16, 2026, 7:51 PM ET

GRAIL Company Profile

Company profile explained

Company Profile

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.

Key Executives

Name Position
Joshua J. Ofman Chief Executive Officer & Director
Abram Barth Chief Legal Officer & Corporate Secretary
Alison Highlander Chief People Officer
Satnam Alag Chief Technology Officer
Aaron Freidin CFO & Head of Corporate Development
Andrew John Partridge Chief Growth Officer
Paul Ciccolella Senior Vice President of Global Development & Operations
Robert Ragusa Advisor
Sir Harpal S. Kumar Chief Scientific Officer and President of Global Clinical & Medical Affairs
Trish Rowland Senior Vice President of Corporate Communications

Latest SEC Filings

Date Type Title
Oct 16, 2026 4 Filing
Oct 16, 2026 4 Filing
Oct 16, 2026 4 Filing
Oct 16, 2026 4 Filing
Oct 07, 2026 4 Filing
Oct 07, 2026 4 Filing
Sep 23, 2026 4 Filing
Sep 23, 2026 4 Filing
Aug 31, 2026 4 Filing
Aug 31, 2026 4 Filing
View All SEC Filings ➞
GRAIL
GRAIL logo
Country United States
IPO Date Jun 12, 2024
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 910
CEO Joshua J. Ofman

Contact Details

1525 O’Brien Drive Menlo Park, California 94025 United States

Stock Details

Ticker Symbol GRAL
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001699031
CUSIP Number 384747101
ISIN Number US3847471014
SIC Code 8071

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.